Position in ALLO
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$74,880
New position
Shares Held
36,000
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#129
of 207 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westmount Partners, LLC holds $2,556,295 across 6 Biotechnology names. ALLO ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,961 | $1,027,677 | |
| 2 | NTHI |
Neonc Technologies Holdings, Inc.
|
197,178 | $893,216 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,118 | $232,228 | |
| 5 | ALLO |
Allogene Therapeutics, Inc.
This page
|
36,000 | $74,880 | |
| 6 | FATE |
Fate Therapeutics Inc
|
10,098 | $27,264 |
All Filings in ALLO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,880 | 36,000 | Shares | Sole | 2026-07-07 | |
| No filing history on record for this holder in this stock. | ||||||